Antimalarial Drug Repurposing of Epirubicin and Pelitinib in Combination with Artemether and Lumefantrine
<b>Background:</b> Drug therapy remains the principal management strategy for malaria but is increasingly challenged by the emergence of drug-resistant malaria parasites. The need for new antimalarial drugs is urgent, yet drug discovery and development are hindered by high costs, long du...
Saved in:
| Main Authors: | Douglas O. Ochora, Reagan M. Mogire, Bernard M. Murithi, Farid Abdi, Erick N. Ondari, Rael J. Masai, Edwin Mwakio, Agnes Cheruyiot, Abiy Yenesew, Hoseah M. Akala |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/7/956 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasmodium falciparum and Schistosoma mansoni coinfection and the side benefit of artemether-lumefantrine in malaria patients
by: Solomon M Abay, et al.
Published: (2013-06-01) -
Comparative in vitro dissolution profiles of marketed Artemether–Lumefantrine adult-dose tablets in Kinshasa, Democratic Republic of the Congo
by: Gloria Bujo Dhimbe, et al.
Published: (2025-06-01) -
Therapeutic efficacy of artemether–lumefantrine in North-Eastern states of India and prevalence of drug resistance-associated molecular markers
by: Shreelekha Dutta, et al.
Published: (2025-04-01) -
Increasing day three parasitaemia is observed after treatment of patients with artemether-lumefantrine and single dose of primaquine for uncomplicated Plasmodium falciparum malaria in Arbaminch Zuria district, Southwest Ethiopia
by: Bontu Abate, et al.
Published: (2025-03-01) -
A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda
by: Daniel Kabonge Kaye, et al.
Published: (2008-04-01)